A detailed history of Vantage Consulting Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Vantage Consulting Group Inc holds 8,463 shares of PFE stock, worth $226,131. This represents 0.39% of its overall portfolio holdings.

Number of Shares
8,463
Previous 8,730 3.06%
Holding current value
$226,131
Previous $242,000 2.48%
% of portfolio
0.39%
Previous 0.36%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$25.26 - $29.6 $6,744 - $7,903
-267 Reduced 3.06%
8,463 $236,000
Q1 2024

May 15, 2024

BUY
$25.89 - $29.73 $15,378 - $17,659
594 Added 7.3%
8,730 $242,000
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $35,850 - $46,565
1,372 Added 20.28%
8,136 $234,000
Q3 2023

Nov 14, 2023

BUY
$32.09 - $37.51 $27,533 - $32,183
858 Added 14.53%
6,764 $224,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $6,357 - $7,355
-176 Reduced 2.89%
5,906 $216,000
Q1 2023

May 10, 2023

BUY
$39.39 - $51.28 $55,618 - $72,407
1,412 Added 30.24%
6,082 $248,000
Q4 2022

Feb 13, 2023

SELL
$41.75 - $54.5 $29,183 - $38,095
-699 Reduced 13.02%
4,670 $239,000
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $24,330 - $29,701
556 Added 11.55%
5,369 $235,000
Q2 2022

Aug 09, 2022

BUY
$46.53 - $55.17 $11,399 - $13,516
245 Added 5.36%
4,813 $252,000
Q1 2022

May 16, 2022

SELL
$45.75 - $56.69 $16,287 - $20,181
-356 Reduced 7.23%
4,568 $236,000
Q4 2021

Feb 14, 2022

SELL
$41.32 - $61.25 $17,478 - $25,908
-423 Reduced 7.91%
4,924 $291,000
Q3 2021

Nov 10, 2021

SELL
$39.25 - $50.42 $11,186 - $14,369
-285 Reduced 5.06%
5,347 $230,000
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $202,245 - $229,109
5,632 New
5,632 $221,000
Q1 2021

May 14, 2021

SELL
$33.49 - $37.77 $59,310 - $66,890
-1,771 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$33.47 - $42.56 $59,275 - $75,373
1,771 New
1,771 $65,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Vantage Consulting Group Inc Portfolio

Follow Vantage Consulting Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vantage Consulting Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vantage Consulting Group Inc with notifications on news.